Cellular therapies in organ transplantation

被引:18
作者
Hoogduijn, Martin J. [1 ]
Issa, Fadi [2 ]
Casiraghi, Federica [3 ]
Reinders, Marlies E. J. [1 ]
机构
[1] Erasmus MC, Dept Internal Med, Erasmus Med Ctr, Nephrol & Transplantat, Rotterdam, Netherlands
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Transplantat Res & Immunol Grp, Oxford, England
[3] Ist Ric Farmacol Mario Negri IRCCS, Bergamo, Italy
基金
英国医学研究理事会;
关键词
cell therapy; immunomodulation; mesenchymal stromal cells; regeneration; regulatory macrophages; regulatory T-cells; MESENCHYMAL STROMAL CELLS; REGULATORY T-CELLS; STEM-CELLS; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; ALLOGRAFT SURVIVAL; EXTRACELLULAR VESICLES; PRETRANSPLANT INFUSION; MACROPHAGES CONTROL; INDUCTION THERAPY;
D O I
10.1111/tri.13789
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cellular therapy is a promising tool for improving the outcome of organ transplantation. Various cell types with different immunoregulatory and regenerative properties may find application for specific transplant rejection or injury-related indications. The current era is crucial for the development of cellular therapies. Preclinical models have demonstrated the feasibility of efficacious cell therapy in transplantation, early clinical trials have shown safety of several of these therapies, and the first steps towards efficacy studies in humans have been made. In this review, we address the current state of the art of cellular therapies in clinical transplantation and discuss monitoring tools and endpoints for these studies.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 116 条
[1]   Cell and Gene Therapy Trials: Are We Facing an 'Evidence Crisis'? [J].
Abou-El-Enein, Mohamed ;
Hey, Spencer Phillips .
ECLINICALMEDICINE, 2019, 7 :13-14
[2]   Putting a price tag on novel autologous cellular therapies [J].
Abou-El-Enein, Mohamed ;
Bauer, Gerhard ;
Medcalf, Nicholas ;
Volk, Hans-Dieter ;
Reinke, Petra .
CYTOTHERAPY, 2016, 18 (08) :1056-1061
[3]   Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use [J].
Alzhrani, Alaa ;
Bottomley, Matthew ;
Wood, Kathryn ;
Hester, Joanna ;
Issa, Fadi .
CELLULAR IMMUNOLOGY, 2020, 357
[4]  
Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101
[5]   Engineering Complex Tissues [J].
Atala, Anthony ;
Kasper, F. Kurtis ;
Mikos, Antonios G. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (160)
[6]   Whole-Organ Tissue Engineering: Decellularization and Recellularization of Three-Dimensional Matrix Scaffolds [J].
Badylak, Stephen F. ;
Taylor, Doris ;
Uygun, Korkut .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13, 2011, 13 :27-53
[7]   Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients [J].
Bank, J. R. ;
Rabelink, T. J. ;
de Fijter, J. W. ;
Reinders, M. E. J. .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[8]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[9]   Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig [J].
Bonham, CA ;
Peng, LS ;
Liang, XY ;
Chen, ZY ;
Wang, LF ;
Ma, LL ;
Hackstein, H ;
Robbins, PD ;
Thomson, AW ;
Fung, JJ ;
Qian, SG ;
Lu, L .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3382-3391
[10]   Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation [J].
Casiraghi, F. ;
Azzollini, N. ;
Todeschini, M. ;
Cavinato, R. A. ;
Cassis, P. ;
Solini, S. ;
Rota, C. ;
Morigi, M. ;
Introna, M. ;
Maranta, R. ;
Perico, N. ;
Remuzzi, G. ;
Noris, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) :2373-2383